Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00017134 · ClinicalTrials.gov registry record · NA
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
A NA study, sponsored by Gynecologic Oncology Group.
- Terminated
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT00017134 is a NA study that was terminated before completion, run by Gynecologic Oncology Group. The registered enrollment target is 71 participants.
The verdict
NCT00017134, a NA study, was terminated before completion, sponsored by Gynecologic Oncology Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether fenretinide given before surgery is more effective in preventing ovarian cancer than surgery alone. PURPOSE: Randomized clinical trial to compare the effectiveness of fenretinide followed by surgery with that of surgery alone in preventing ovarian cancer in patients who are at increased risk.
Interventions
- PROCEDURE conventional surgery
- DRUG fenretinide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2002-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00017134
The ClinicalTrials.gov registry entry for NCT00017134 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00017134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00017134 about?
NCT00017134 is a clinical study titled "Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether fenretinide given before surgery is more effective in preventing ovarian cancer than surgery alone. PURPOSE: Randomized clinical trial to compare the effectiveness...
What is the current status of trial NCT00017134?
This trial is currently terminated. It is a NA study. The enrollment target is 71 participants. The study started on 2002-09.
What interventions are being tested in trial NCT00017134?
The interventions under investigation include: conventional surgery (PROCEDURE), fenretinide (DRUG).
Who is sponsoring clinical trial NCT00017134?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.